Zobrazeno 1 - 10
of 153
pro vyhledávání: '"Fumikata Hara"'
Autor:
Fumikata Hara, Reiko Nagasaki, Reiko Minami, Tadahiro Izutani, Takahiro Yoshida, Ayako Arai, Akiko Nihei, Naomi Sakurai, Shinji Ohno
Publikováno v:
BMC Women's Health, Vol 24, Iss 1, Pp 1-10 (2024)
Abstract Background In the breast cancer treatment, there may be a gap between patients’ information needs and physicians’ perceptions. To address this issue, we conducted a comprehensive questionnaire survey aimed to assess the specific informat
Externí odkaz:
https://doaj.org/article/0f6758392a3c4849b60a8b20b7625460
Autor:
Takayuki Kobayashi, Meiko Nishimura, Mari Hosonaga, Rika Kizawa, Saori Kawai, Yosuke Aoyama, Yukinori Ozaki, Ippei Fukada, Fumikata Hara, Toshimi Takano, Takayuki Ueno
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-7 (2024)
Abstract Background Absolute lymphocyte count (ALC) is a predictive and prognostic factor for various tumor types, including breast cancer. Palbociclib is a CDK4/6 inhibitor widely used for the treatment of metastatic estrogen receptor (ER)-positive,
Externí odkaz:
https://doaj.org/article/1e6f7c53792d4145b42f0e111048dcb5
Autor:
Chikako Funasaka, Akiko Hanai, Sadamoto Zenda, Keita Mori, Makoto Fukui, Nami Hirano, Rie Shinohara, Nozomu Fuse, Masashi Wakabayashi, Mai Itagaki, Yutaka Tomioka, Michihiko Nishina, Yasuaki Arai, Takahiro Kogawa, Yukinori Ozaki, Meiko Nishimura, Takayuki Kobayashi, Fumikata Hara, Toshimi Takano, Toru Mukohara
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
BackgroundChemotherapy-induced peripheral neuropathy (CIPN) is one of the most common adverse events that can significantly impair the quality of life of patients. Although limb cooling may be beneficial for preventing CIPN, logistical challenges exi
Externí odkaz:
https://doaj.org/article/e1de7bd468ee4989bc20236eaa2dcef1
Autor:
Yukinori Ozaki, Jun Masuda, Akemi Kataoka, Takahiro Kogawa, Tomomi Abe, Hidetomo Morizono, Lina Inagaki, Fumikata Hara, Toshimi Takano, Takayuki Ueno, Shinji Ohno
Publikováno v:
Cancer Reports, Vol 6, Iss 2, Pp n/a-n/a (2023)
Abstract Background Higher body mass index (BMI) is associated with worse prognosis in pre‐ and postmenopausal patients with breast cancer (BC). However, there is insufficient evidence regarding the optimal adjuvant endocrine therapy for obese prem
Externí odkaz:
https://doaj.org/article/b0e2d166fdaa4cd7ba08f87b91a38b35
Autor:
Ippei Fukada, Seiichi Mori, Naomi Hayashi, Mari Hosonaga, Masumi Yamazaki, Xiaofei Wang, Saori Kawai, Lina Inagaki, Yukinori Ozaki, Kokoro Kobayashi, Fumikata Hara, Takayuki Kobayashi, Arisa Ueki, Tomo Osako, Akiko Tonooka, Kengo Takeuchi, Takayuki Ueno, Toshimi Takano, Shinji Ohno, Shunji Takahashi
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-9 (2022)
Abstract Comprehensive cancer genomic profile (CGP) tests are being implemented under Japanese universal health insurance system. However, the clinical usefulness of CGP test for breast cancer patients has not been evaluated. Of the 310 patients who
Externí odkaz:
https://doaj.org/article/89eefc4b8f4f4335bd68ccdd4835a126
Autor:
Yukinori Ozaki, Yosuke Aoyama, Jun Masuda, Lina Inagaki, Saori Kawai, Tomoko Shibayama, Tetsuyo Maeda, Mami Kurata, Kazuyo Yoshida, Sumito Saeki, Mari Hosonaga, Ippei Fukada, Fumikata Hara, Takayuki Kobayashi, Kokoro Kobayashi, Satoshi Miyake, Toshimi Takano, Takayuki Ueno, Shinji Ohno
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-7 (2022)
Abstract Background Trastuzumab and fulvestrant combination therapy is one of the treatment options for patients with hormone receptor- and human epidermal growth factor receptor 2 (HER2)-positive metastatic breast cancer; however, there are limited
Externí odkaz:
https://doaj.org/article/dd5e175ef3214c6889e932fed7778e8e
Autor:
Junji Tsurutani, Fumikata Hara, Masahiro Kitada, Masato Takahashi, Yuichiro Kikawa, Hiroaki Kato, Eiko Sakata, Yoichi Naito, Yoshie Hasegawa, Tsuyoshi Saito, Tsutomu Iwasa, Naruto Taira, Tsutomu Takashima, Kosuke Kashiwabara, Tomohiko Aihara, Hirofumi Mukai
Publikováno v:
Breast, Vol 55, Iss , Pp 63-68 (2021)
Background: Chemotherapy-induced peripheral neuropathy is commonly observed in patients treated with nanoparticle albumin–bound paclitaxel (nab-PTX). We conducted a multicenter randomized controlled study to evaluate the optimal dose of nab-PTX. Me
Externí odkaz:
https://doaj.org/article/47ae3af95d7143318f7fa81b47457151
Autor:
Yuko, Abe, Naruto, Taira, Kosuke, Kashiwabara, Junji, Tsurutani, Masahiro, Kitada, Masato, Takahashi, Hiroaki, Kato, Yuichiro, Kikawa, Eiko, Sakata, Yoichi, Naito, Yoshie, Hasegawa, Tsuyoshi, Saito, Tsutomu, Iwasa, Tsutomu, Takashima, Tomohiko, Aihara, Hirofumi, Mukai, Fumikata, Hara, Tadahiko, Shien, Hiroyoshi, Doihara, Shinichi, Toyooka
Publikováno v:
Acta Medica Okayama. 76(6):661-671
Chemotherapy-induced peripheral neuropathy (CIPN) is an important clinical challenge that threatens patients’ quality of life. This sub-study of the ABROAD trial investigated the influence of single nucleotide polymorphisms (SNPs) on CIPN, using ge
Autor:
Yukinori Ozaki, Jun Masuda, Akemi Kataoka, Takahiro Kogawa, Tomomi Abe, Hidetomo Morizono, Lina Inagaki, Fumikata Hara, Toshimi Takano, Takayuki Ueno, Shinji Ohno
Publikováno v:
Cancer Research. 82:P4-11
Background: Obesity is related to poor prognosis in pre- and postmenopausal patients with breast cancer. However, there is insufficient evidence regarding the optimal adjuvant hormone therapy for obese premenopausal women with hormone receptor-positi
Autor:
Tsuguo Iwatani, Fumikata Hara, Tadahiko Shien, Masato Takahashi, Norikazu Masuda, Yasuaki Sagara, Keita Sasaki, Junki Mizusawa, Haruhiko Fukuda, Takaru Shiroiwa, Hiroji Iwata
Publikováno v:
Cancer Research. 82:P3-16
Background In 2019, the Japanese government has introduced the economic valuation to healthcare system. However, the threshold for determining cost-effectiveness-analysis has yet to be adequately studied. Therefore, we have designed a study to examin